Hypocalcémie par hypomagnésémie au cours d'un traitement par cisplatine

Revue de Medecine Interne

Volumn 17, Issue 6, 1996, Pages 498-

  Brousse, C ^a   Baumelou, E ^a   Mignot, L ^a  

^a FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; ANTINEOPLASTIC AGENT; MAGNESIUM;

ADULT; CASE REPORT; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; LETTER; LUNG CANCER; MALE; BLOOD; MIDDLE AGED;

ANTINEOPLASTIC AGENTS; CISPLATIN; HUMANS; HYPOCALCEMIA; MAGNESIUM; MALE; MIDDLE AGED;

EID: 16144367996     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)86446-0     Document Type: Letter

References (4)

1. Perry MC. The Chemotherapy Source Book. Baltimore : Williams et Wilkins, 1992
2. Leicht E, Bird G. Mechanisms of hypocalcemia in the clinical form of severe magnesium deficit in the human. Magnes Res 1992;5:37-44
3. MacLean RM. Magnesium and its therapeutic uses: a review. Am J Med 1994;96:63-76
4. Lam M, Adelstein DJ. Hypomagnesemia and renal magnesium wasting in patients treated with Cisplatin. Am J Kidney Dis 1986;3:164-9